AMDC-USR (iltamiocel) for urinary incontinence, stress

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 7 Apr 2017: Trial registered, NCT03104517
  2. 23 Apr 2019: Trial started, NCT03104517

The trials

NCT03104517: Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence

State
Under way
Phase
Phase 3
People
96 planned
Started
23 Apr 2019
Primary completion
11 Jun 2026
Arms
AMDC-USR (iltamiocel)
Results
None posted
  1. 7 Apr 2017: Trial registered
  2. 23 Apr 2019: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.